Samsrita Labs Limited has announced a key addition to its leadership team, strengthening its corporate governance structure. The company's Board of Directors has approved the appointment of Mrs. M. Gita Usha Rani as the new Company Secretary and Compliance Officer, effective September 8, 2025.

Board Meeting Details

The decision was made during a board meeting held on September 8, 2025, at the company's registered office. The meeting commenced at 3:30 p.m. and concluded at 5:00 p.m.

About Mrs. M. Gita Usha Rani

Mrs. Rani brings a wealth of experience to her new role at Samsrita Labs:

• Qualifications: Qualified Company Secretary
• Experience: Over 8 years in secretarial work
• Shareholding: Currently holds no shares in Samsrita Labs Limited
• Relationships: No relationships with other directors on the board

Terms of Appointment

The appointment of Mrs. M. Gita Usha Rani will follow the existing norms for Key Managerial Personnel (KMP) of Samsrita Labs Limited, ensuring consistency in the company's executive management structure and compliance with corporate governance standards.

Regulatory Compliance

This appointment has been made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Samsrita Labs has duly informed both the BSE Limited and the Metropolitan Stock Exchange of India Limited about this development.

Company Leadership

The announcement was made by Mr. K. Krishnam Raju, the Chairman and Whole-time Director of Samsrita Labs Limited, underlining the importance of this appointment in the company's corporate structure.

This strategic appointment is expected to enhance Samsrita Labs' corporate governance practices and ensure compliance with regulatory requirements as the company moves forward in its business operations.

Samsrita Labs Limited , a company listed on BSE Limited and Metropolitan Stock Exchange of India Limited, has seen a significant change in its shareholding structure. Four members of the Basaboini family have acquired a combined 6.6% stake in the company through a preferential allotment on July 18, 2025.

Details of the Acquisition

The preferential allotment involved the following acquisitions:

The acquisition was made on a cash basis through the preferential issue. It's worth noting that the acquirers did not belong to the promoter group and had no previous holdings in the company.

Impact on Share Capital

Following this acquisition, Samsrita Labs' total equity share capital has increased significantly:

• Before Acquisition: 1,48,08,706 equity shares of Rs. 10 each
• After Acquisition: 2,27,49,710 equity shares of Rs. 10 each

This represents an increase of 79,41,004 shares, or approximately 53.6% in the total number of outstanding shares.

Regulatory Compliance

In compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the acquirers have filed the necessary disclosures under Regulation 29(1). These disclosures were submitted to both BSE Limited and Metropolitan Stock Exchange of India Limited on July 21, 2025.

Company Background

Samsrita Labs Limited is headquartered at 6-3-354/13/B2, Flat.No.B2, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad-500082, Telangana, India. The company's shares are listed on both BSE Limited and Metropolitan Stock Exchange of India Limited.

This preferential allotment and the resulting change in shareholding structure could potentially impact the company's governance and strategic direction. Investors and market watchers will likely be keen to observe any subsequent changes in the company's operations or performance following this significant acquisition.